Beijing Foyou Pharma CO.,LTD (SHA:601089)
18.14
+1.13 (6.64%)
At close: Aug 20, 2026
SHA:601089 Revenue
Beijing Foyou Pharma CO.,LTD had revenue of 898.98M CNY in the quarter ending June 30, 2026, with 11.88% growth. This brings the company's revenue in the last twelve months to 3.58B, up 4.57% year-over-year. In the year 2025, Beijing Foyou Pharma CO.,LTD had annual revenue of 3.50B with 1.71% growth.
Revenue (ttm)
3.58B
Revenue Growth
+4.57%
P/S Ratio
2.37
Revenue / Employee
916.23K
Employees
3,908
Market Cap
8.49B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.50B | 58.80M | 1.71% |
| Dec 31, 2024 | 3.45B | 106.01M | 3.17% |
| Dec 31, 2023 | 3.34B | 99.48M | 3.07% |
| Dec 31, 2022 | 3.24B | 402.44M | 14.18% |
| Dec 31, 2021 | 2.84B | 302.37M | 11.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.13B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Zhejiang Xianju Pharmaceutical | 3.67B |
| Zhejiang Tianyu Pharmaceutical | 3.11B |
| Sunflower Pharmaceutical Group | 2.50B |
| Jiuzhitang | 2.40B |
| Guilin Sanjin Pharmaceutical | 2.10B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |